Cargando…

Pain Management in Patients with Multiple Myeloma: An Update

Most patients with multiple myeloma (MM) suffer from chronic pain at every stage of the natural disease process. This review focuses on the most common causes of chronic pain in MM patients: (1) pain from myeloma bone disease (MBD); (2) chemotherapy-induced peripheral neuropathy as a possible conseq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coluzzi, Flaminia, Rolke, Roman, Mercadante, Sebastiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966684/ https://www.ncbi.nlm.nih.gov/pubmed/31861097 http://dx.doi.org/10.3390/cancers11122037

Ejemplares similares

Factors Influencing Pain Expression in Patients with Cancer: An Expert Opinion
por: Mercadante, Sebastiano, et al.
Publicado: (2021)

Acute postoperative pain management: focus on iontophoretic transdermal fentanyl
por: Mattia, Consalvo, et al.
Publicado: (2007)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease
por: Coluzzi, Flaminia, et al.
Publicado: (2015)

Chronic non-cancer pain: Focus on once-daily tramadol formulations
por: Coluzzi, Flaminia, et al.
Publicado: (2007)

Once again... breakthrough cancer pain: an updated overview
por: Mercadante, Sebastiano
Publicado: (2023)

The Impact of P-Glycoprotein on Opioid Analgesics: What’s the Real Meaning in Pain Management and Palliative Care?
por: Coluzzi, Flaminia, et al.
Publicado: (2022)

Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments
por: Coluzzi, Flaminia, et al.
Publicado: (2020)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

The challenge of perioperative pain management in opioid-tolerant patients
por: Coluzzi, Flaminia, et al.
Publicado: (2017)

Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide
por: Schoenbeck, Kelly L, et al.
Publicado: (2020)

Analysis of Updates in Multiple Myeloma Treatment and Management
por: Nieto, Maria Jacqueline, et al.
Publicado: (2023)

Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
por: Abramson, Hanley N.
Publicado: (2018)

Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
por: Coluzzi, Flaminia, et al.
Publicado: (2020)

Recent updates on CAR T clinical trials for multiple myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Update on the optimal use of bortezomib in the treatment of multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2017)

Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
por: Coluzzi, Flaminia, et al.
Publicado: (2022)

Bortezomib-induced painful neuropathy in patients with multiple myeloma
por: Bilińska, Małgorzata, et al.
Publicado: (2013)

The Use of Parenteral Opioids in Cancer Pain Management
por: Mercadante, Sebastiano
Publicado: (2023)

Multiple myeloma: an overview of management
por: Bird, Sarah Anne, et al.
Publicado: (2019)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review
por: Nishida, Hiroko
Publicado: (2021)

Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: patients’ selection and perspective
por: Trudel, Sabrina, et al.
Publicado: (2019)

Interventional Techniques for the Management of Cancer-Related Pain: Clinical and Critical Aspects
por: Kurita, Geana Paula, et al.
Publicado: (2019)

Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
por: Jelinek, Tomas, et al.
Publicado: (2018)

Management of cardiovascular risk in patients with multiple myeloma
por: Plummer, Chris, et al.
Publicado: (2019)

Epidemiology, Staging, and Management of Multiple Myeloma
por: Padala, Sandeep Anand, et al.
Publicado: (2021)

How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma
por: de Arriba de la Fuente, Felipe, et al.
Publicado: (2022)

Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses
por: Georgakopoulou, Rebecca, et al.
Publicado: (2021)

Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management
por: Mercadante, Sebastiano
Publicado: (2019)

Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

The Patient with Difficult Cancer Pain
por: Mercadante, Sebastiano
Publicado: (2019)

Refractory Cancer Pain and Intrathecal Therapy: Critical Review of a Systematic Review
por: Mercadante, Sebastiano
Publicado: (2023)

Update on the pharmacogenomics of pain management
por: Kaye, Alan David, et al.
Publicado: (2019)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tosi, P., et al.
Publicado: (2012)

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
por: Nijhof, Inger S., et al.
Publicado: (2017)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
por: Grammatico, Sara, et al.
Publicado: (2016)

Bone Disease in Multiple Myeloma: Pathophysiology and Management
por: Hameed, Abdul, et al.
Publicado: (2014)

Recent Advances in the Management of Smoldering Multiple Myeloma
por: Madhira, Bhaskara Reddy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n1c7m5h28nl8ie8c5qle12n610